In a nutshell This study investigated the effects of adding ixazomib (Ninlaro) to lenalidomide (Revlimid) and dexamethasone (Dexasone) for patients with unresponsive multiple myeloma. The main finding was that patients receiving ixazomib plus lenalidomide and dexamethasone survived longer without worsening of cancer (progression-free...
Read More
Home »
On going treatment(s)-Other
On going treatment(s)-Other Posts on Medivizor
To receive all the
cutting-edge updates personally relevant to you
(free and private)
Categories
- Benign prostatic hyperplasia
- Blog
- Breast cancer
- Cancer
- Colorectal cancer
- Coronary artery disease
- Coronavirus / COVID-19
- Diabetes mellitus
- Erectile dysfunction
- Hodgkin's lymphoma
- Hypertension
- Infertility
- Kidney stones
- Leukemia
- Lung cancer
- Lymphoma
- Melanoma
- Men's Health
- Mental Health
- Multiple Myeloma
- Nocturia
- Non-Hodgkin lymphoma
- Overactive bladder
- Parkinson's Disease
- Prostate cancer
- Rare disease
- Rheumatoid Arthritis
- Stroke
- Urinary incontinence
- Urinary tract infection
Recent Posts
- Unlocking A Mystery: Mast Cells, Hypermobile Ehlers-Danlos Syndrome, and Genes
- Periodontal Disease: Keep your teeth clean for better health
- Evaluating the pulsed solid-state Thulium: YAG laser in men with benign prostatic hyperplasia in a real-world setting
- Comparing the safety and effectiveness of hormonal therapy alone versus chemo-hormonal therapy before prostate surgery in men with locally advanced prostate cancer
- Evaluating the Vigor 2020 vacuum erection device for erectile dysfunction